ONTO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ONTO is not a good buy right now for an impatient trader. Despite a longer-term uptrend (bullish moving averages), near-term momentum is weakening (negative and expanding MACD histogram) and the stock is trading below the key pivot (~214.15) in pre-market. With no proprietary buy signals today and short-term pattern odds skewing slightly negative over the next month, the risk/reward for an immediate entry is unattractive versus waiting for a clearer momentum turn or a cleaner support-based entry.
Trend/structure: The moving-average stack is bullish (SMA_5 > SMA_20 > SMA_200), which supports an intermediate uptrend. However, momentum has deteriorated: MACD histogram is -0.617 and negatively expanding, signaling strengthening bearish momentum in the short run. RSI_6 at ~64.9 is neutral-to-warm (not oversold), meaning there isn’t a clear mean-reversion buy setup.
Key levels: Pre-market ~209.98 sits below the pivot (214.148), which is a short-term bearish tell. Nearby support is S1 ~204.465 (then S2 ~198.482). Resistance levels are R1 ~223.832 and R2 ~229.815.
Price path bias: The candlestick-pattern analog suggests muted downside near-term (50% chance of -1.1% next day) and a weaker 1-month skew (-4.18%), aligning with the negative MACD.
Intellectia Proprietary Trading Signals: Intellectia Proprietary Trading Signals
Upcoming earnings: QDEC 2025 earnings on 2026-02-09 (after hours) with Street EPS est. ~1.27 could be a catalyst if guidance confirms improving semicap demand.
Analyst commentary tailwinds: Needham cited broad-based demand improvement over the past ~90 days and expects multiple catalysts into Q4 earnings; Jefferies highlighted AI-driven lift to semiconductor capex; Evercore positioned ONTO to benefit from memory/HBM re-acceleration.
Sentiment/flows: Options market is call-skewed (bullish positioning). Hedge funds/insiders show neutral activity (no notable selling pressure flagged).
or ~198 (S2).
Latest quarter: 2025/Q3.
Growth trends: Revenue fell to ~$218.19M (-13.49% YoY). Profitability also weakened: net income ~$28.22M (-46.80% YoY) and EPS $0.57 (-46.73% YoY). A bright spot was gross margin, which improved to ~50.18% (+1.78% YoY), suggesting better mix/pricing or cost control even as top-line demand was softer. Overall, the quarter reflects a downcycle/air pocket rather than accelerating growth right now.
Recent trend: Price targets have generally moved higher into late 2025 and January 2026, reflecting improving semicap/HBM expectations. Needham raised PTs multiple times (to $200 on 2026-01-06 and then to $260 on 2026-01-20) while maintaining Buy; Jefferies raised to $200 (Buy); Evercore raised to $160 (Outperform); B. Riley raised to $180 (Buy). Offsetting this, Cantor kept a Neutral (PT $170) and Stifel remained Hold with a notably lower PT ($126) and warned of potential choppiness into Q1.
Wall Street pros: Improving demand commentary, AI/HBM/memory spend re-acceleration theme, multiple firms raising targets.
Wall Street cons: Some caution on near-term visibility and choppiness (Stifel), and at least one Neutral stance (Cantor). Needham also removed ONTO from its Conviction List (in favor of another name) even while keeping a Buy, which slightly tempers the enthusiasm.
